Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: ENVX stock price vs LLY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LLY's multiple
Needs LLY P/S.
Implied fair value · at ENVX's multiple
Needs ENVX P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ENVX FY 2025 (ended Dec 28, 2025) · LLY FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Enovix Corporation · implied price per share
Bear
-$0.37
Base
-$0.43
Bull
-$0.50
ELI LILLY AND COMPANY · implied price per share
Bear
$191.97
Base
$225.85
Bull
$259.72
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.95x
1.60x
Net debt / EBITDA
Leverage against operating earnings
-0.15x
1.22x
Cash and equivalents
Liquid reserves on the balance sheet
$512.04M
$7.42B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
QuantumScape Corp
ENVX vs QS
Eos Energy Enterprises, Inc.
ENVX vs EOSE
Microvast Holdings, Inc.
ENVX vs MVST
AEHR TEST SYSTEMS
ENVX vs AEHR
Pfizer Inc.
ENVX vs PFE
Merck & Co., Inc.
ENVX vs MRK
Johnson & Johnson
ENVX vs JNJ
AbbVie Inc.
ENVX vs ABBV
Amgen Inc.
ENVX vs AMGN
Bristol-Myers Squibb Company
ENVX vs BMY
$529.37M
$42.50B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
